CVS Health (CVS) Tops Q1 EPS by 6c, Q2 EPS Guidance Tops Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
CVS Health Reports First Quarter Results And Confirms 2018 Full Year Outlook
May 2, 2018 6:55 AM EDTWOONSOCKET, R.I., May 2, 2018 /PRNewswire/ --Â
First Quarter Year-over-Year Highlights:
Net revenues increased 2.6% to $45.7 billion Retail/LTC same store prescription volume growth of 8.5% GAAP diluted EPS from continuing operations of $0.98 Adjusted EPS of $1.48, which reflects an additional adjustment for net interest expense from the proposed Aetna acquisition2018 Full Year Guidance:
GAAP operating profit growth of down 0.25% to up 2.75% Adjusted operating profit growth of down 1.5% to up 1.5% GAAP diluted EPS from continuing operations of $5.11 to... More